XML 27 R5.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statement Of Cash Flows - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Operating Activities    
Net loss $ (13,886,000) $ (14,108,000)
Adjustments to reconcile net loss to net cash used by operating activities:    
Depreciation and amortization 3,898,000 4,111,000
Operating Lease, Right-of-Use, Amortization 2,172,000 0
Provision for losses on trade and installment receivables 185,000 201,000
Provision (benefit) for deferred income taxes 329,000 (3,000)
Provision for other deferred liabilities 234,000 (66,000)
Provision for equity compensation 1,430,000 1,766,000
Loss on disposals of property and equipment 54,000 35,000
Amortization of convertible debt discount 3,099,000 2,786,000
Amortization of debt fees 615,000 620,000
Loss (Gain) on convertible debt derivatives (273,000) 103,000
Changes in operating assets and liabilities:    
Trade receivables 3,535,000 (930,000)
Installment sales contracts, net 13,000 141,000
Inventories (1,588,000) (8,713,000)
Other current assets (3,957,000) (1,653,000)
Accounts payable (4,683,000) 2,759,000
Accrued expenses (12,794,000) (11,509,000)
Other long-term liabilities (1,517,000) 15,000
Net Cash Used by Operating Activities (22,588,000) (24,651,000)
Investing Activities    
Purchases of property and equipment (1,812,000) (2,065,000)
Proceeds from sale of property and equipment 20,000 10,000
Change in other long-term assets (20,000) (228,000)
Net Cash Used by Investing Activities (1,812,000) (2,283,000)
Financing Activities    
Payments on revolving lines of credit, long-term borrowings and capital leases (866,000) (393,000)
Proceeds from exercise of stock options 0 1,410,000
Payment of dividends (408,000) (403,000)
Purchase of treasury stock (381,000) (920,000)
Net Cash Used by Financing Activities (1,655,000) (306,000)
Effect of exchange rate changes on cash 1,074,000 1,330,000
Decrease in cash and cash equivalents (24,981,000) (25,910,000)
Cash and cash equivalents at beginning of year 116,907,000 176,528,000
Cash and cash equivalents at end of period $ 91,926,000 $ 150,618,000